BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 27582469)

  • 1. Parent-of-origin effects of A1CF and AGO2 on testicular germ-cell tumors, testicular abnormalities, and fertilization bias.
    Carouge D; Blanc V; Knoblaugh SE; Hunter RJ; Davidson NO; Nadeau JH
    Proc Natl Acad Sci U S A; 2016 Sep; 113(37):E5425-33. PubMed ID: 27582469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transgenerational epigenetic effects of the Apobec1 cytidine deaminase deficiency on testicular germ cell tumor susceptibility and embryonic viability.
    Nelson VR; Heaney JD; Tesar PJ; Davidson NO; Nadeau JH
    Proc Natl Acad Sci U S A; 2012 Oct; 109(41):E2766-73. PubMed ID: 22923694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of piRNA biogenesis and function in testicular germ cell tumors and their precursor germ cell neoplasia in situ.
    Gainetdinov IV; Skvortsova YV; Kondratieva SA; Klimov A; Tryakin AA; Azhikina TL
    BMC Cancer; 2018 Jan; 18(1):20. PubMed ID: 29301509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apobec1 complementation factor (A1CF) and RBM47 interact in tissue-specific regulation of C to U RNA editing in mouse intestine and liver.
    Blanc V; Xie Y; Kennedy S; Riordan JD; Rubin DC; Madison BB; Mills JC; Nadeau JH; Davidson NO
    RNA; 2019 Jan; 25(1):70-81. PubMed ID: 30309881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of RNA Editing Activity of APOBEC1-A1CF and APOBEC1-RBM47 Complexes Reconstituted in HEK293T Cells.
    Wolfe AD; Arnold DB; Chen XS
    J Mol Biol; 2019 Mar; 431(7):1506-1517. PubMed ID: 30844405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. APOBEC1 complementation factor (A1CF) is dispensable for C-to-U RNA editing in vivo.
    Snyder EM; McCarty C; Mehalow A; Svenson KL; Murray SA; Korstanje R; Braun RE
    RNA; 2017 Apr; 23(4):457-465. PubMed ID: 28069890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Ter mutation in the dead end gene causes germ cell loss and testicular germ cell tumours.
    Youngren KK; Coveney D; Peng X; Bhattacharya C; Schmidt LS; Nickerson ML; Lamb BT; Deng JM; Behringer RR; Capel B; Rubin EM; Nadeau JH; Matin A
    Nature; 2005 May; 435(7040):360-4. PubMed ID: 15902260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apobec-1 complementation factor regulates cell migration and apoptosis through Dickkopf1 by acting on its 3' untranslated region in MCF7 cells.
    Yan X; Li Q; Ni D; Xie Y; He Q; Wan Q; Liu Y; Lyu Z; Mao Z; Zhou Q
    Tumour Biol; 2017 Jun; 39(6):1010428317706218. PubMed ID: 28639893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C to U RNA editing mediated by APOBEC1 requires RNA-binding protein RBM47.
    Fossat N; Tourle K; Radziewic T; Barratt K; Liebhold D; Studdert JB; Power M; Jones V; Loebel DA; Tam PP
    EMBO Rep; 2014 Aug; 15(8):903-10. PubMed ID: 24916387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testicular germ cell tumor: a comprehensive review.
    Batool A; Karimi N; Wu XN; Chen SR; Liu YX
    Cell Mol Life Sci; 2019 May; 76(9):1713-1727. PubMed ID: 30671589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testicular germ cell tumors in mice: new ways to study a genetically complex trait.
    Heaney JD; Nadeau JH
    Methods Mol Biol; 2008; 450():211-31. PubMed ID: 18370062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetically-biased fertilization in APOBEC1 complementation factor (A1cf) mutant mice.
    Hirose N; Blanchet G; Yamauchi Y; Snow AC; Friedman R; Khoo CY; Lary CW; Ward MA; Nadeau JH
    Sci Rep; 2022 Aug; 12(1):13599. PubMed ID: 35948620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of epigenetic modifiers in the pathogenesis of testicular dysgenesis and germ cell cancer.
    Lawaetz AC; Almstrup K
    Biomol Concepts; 2015 Jun; 6(3):219-27. PubMed ID: 26103631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of RBM46 as a novel APOBEC1 cofactor for C-to-U RNA-editing activity.
    Wang S; Kim K; Gelvez N; Chung C; Gout JF; Fixman B; Vermulst M; Chen XS
    J Mol Biol; 2023 Dec; 435(24):. PubMed ID: 38708190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous metastasis in mouse models of testicular germ-cell tumours.
    Zechel JL; MacLennan GT; Heaney JD; Nadeau JH
    Int J Androl; 2011 Aug; 34(4 Pt 2):e278-87. PubMed ID: 21651572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression profiles of PIWIL2 short isoforms differ in testicular germ cell tumors of various differentiation subtypes.
    Gainetdinov IV; Skvortsova YV; Stukacheva EA; Bychenko OS; Kondratieva SA; Zinovieva MV; Azhikina TL
    PLoS One; 2014; 9(11):e112528. PubMed ID: 25384072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic changes associated with testicular cancer susceptibility.
    Pyle LC; Nathanson KL
    Semin Oncol; 2016 Oct; 43(5):575-581. PubMed ID: 27899190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erasure of methylation imprint at the promoter and CTCF-binding site upstream of H19 in human testicular germ cell tumors of adolescents indicate their fetal germ cell origin.
    Kawakami T; Zhang C; Okada Y; Okamoto K
    Oncogene; 2006 Jun; 25(23):3225-36. PubMed ID: 16434968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trans-generational epistasis between Dnd1Ter and other modifier genes controls susceptibility to testicular germ cell tumors.
    Lam MY; Heaney JD; Youngren KK; Kawasoe JH; Nadeau JH
    Hum Mol Genet; 2007 Sep; 16(18):2233-40. PubMed ID: 17616517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Search for testicular cancer gene hits dead-end.
    Matin A; Nadeau JH
    Cell Cycle; 2005 Sep; 4(9):1136-8. PubMed ID: 16082220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.